Ушбу иш иқтибос қилган ишлар

111 та иш

Иш: Biomimetic camouflage delivery strategies for cancer therapy

Blood–Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery <i>via</i> Albumin-Binding Protein Pathways for Antiglioma Therapy
Tingting Lin, Pengfei Zhao, Yifan Jiang +6
Мақола20165 иқтибос
ABI
Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide
Xiaopeng Mo, Zening Zheng, Yang He +6
Мақола20185 иқтибос
ABI
Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery
Yingzhi Chen, Meng Zhang, Hongyue Jin +5
Мақола20174 иқтибос
ABI
Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity
Pengfei Zhao, Jiaxin Zhang, Aihua Wu +8
Мақола20203 иқтибос
ABI
Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy
Pengfei Zhao, Weimin Yin, Aihua Wu +8
Мақола20173 иқтибос
ABI
Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation
Dongdong Li, Meng Zhang, Fan Xu +6
Мақола20173 иқтибос
ABI
Cell Membrane Coating Nanotechnology
Ronnie H. Fang, Ashley V. Kroll, Weiwei Gao +1
Шарҳ мақола20183 иқтибос
ABI
PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study
Meong Cheol Shin, Jian Zhang, Kyoung Ah Min +4
Мақола20153 иқтибос
ABI
Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy
Huiyuan Wang, Cheol Moon, Meong Cheol Shin +4
Шарҳ мақола20173 иқтибос
ABI
New Look to Phytomedicine
Китоб20183 иқтибос
ABI
Structures of the Cd44–hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction
Suneale Banerji, Alan J. Wright, M.E.M. Noble +4
Мақола20072 иқтибос
ABI
Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer
Samar M. Etman, Ossama Y. Abdallah, Radwa A. Mehanna +1
Мақола20202 иқтибос
ABI
Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs
Elmira Karami, Mahdi Behdani, Fatemeh Kazemi‐Lomedasht
Мақола20192 иқтибос
ABI
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang, Che‐Ming Jack Hu, Brian T. Luk +5
Мақола20142 иқтибос
ABI
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Huiping Sun, Jinghan Su, Qingshuo Meng +8
Мақола20162 иқтибос
ABI
Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy
Shiying Li, Hong Cheng, Bo‐Ru Xie +7
Мақола20172 иқтибос
ABI
Impact of structurally modifying hyaluronic acid on CD44 interaction
Deep Bhattacharya, Denis Svechkarev, Joshua J. Souchek +4
Мақола20172 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI